Immediate Impact

1 from Science/Nature 60 standout
Sub-graph 1 of 23

Citing Papers

Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
1 intermediate paper

Works of C. Angerstein being referenced

Therapeutic advantages of Auger electron- over β-emitting radiometals or radioiodine when conjugated to internalizing antibodies
2000

Author Peers

Author Last Decade Papers Cites
C. Angerstein 189 288 182 14 427
Thomas Pangerl 281 158 216 14 438
Gabriela N. Doeswijk 162 182 172 11 378
J E Westlin 180 212 229 18 508
Stefano Papi 177 180 190 25 440
Stuart Koelewijn 134 138 156 12 404
Eric von Benzon 157 200 188 15 405
Marcel E. van der Pluijm 307 319 258 8 501
John G. Wolbers 167 124 90 13 464
Eleni Mavriopoulou 164 166 343 10 450
Julliëtte E M van Eerd 93 315 164 13 493

All Works

Loading papers...

Rankless by CCL
2026